MENU
JUNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Jupiter Neurosciences (JUNS) Ownership - Who owns Jupiter Neurosciences?

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.87M
P/E Ratio
N/A
Total Cash
723.8K
Projected Growth
N/A
Total Debt
180.39K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

JUNS
Capitalization
37.9M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
724K
Total Cash/Share
0.02
Total Debt
180K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
57.4K
P/B Ratio
666.67
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.43K
Current Ratio
0.65
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-570.85
Shares Held By Institutions
2.22M
Shares Outstanding - Current
34.4M
Total Liabilities
2.52M
Total Volume MTD
N/A
Value
-1
Gain YTD
-89.720
View a ticker or compare two or three
JUNS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JUNS showed earnings on December 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details